| Study summary: |
|
Long term safety study to look at safety and tolerability of adding a new study medication while continuing to take prescribed anti-depressant; wanting subjects who are partial responders to current SSRI anti-depressant medication. |
| Qualified participants must: |
|
• Be 18 years of age or older
•
Be currently taking prescribed SSRI medication for depression for at least the past 6 weeks
•
Have a lack of response of current depression symptoms to 2 or more therapeutic courses of anti-depressant medication treatment
•
Have symptoms that should include pervasive depressed mood or loss of interest that occurs for at least 2 weeks along with other core symptomes of fatigue, difficulty concentrating, feelings of worthlessness, sleep and appetite disturbances
•
Have not participated in a study within the past 30 days
•
Not have anxiety disorder, PTSD, obsessive compulsive disorder as a concurrent Diagnosis
•
Not have bipolar, schizophrenia or other psychotic disorders
•
Have ho history of ECT within past year
•
Not have seizure disorders
•
Be taking birth control
•
If alcoholic, must be clean and sober for at least one year
|
| Participants may receive: |
|
A free medical evaluation and appointment with our physician, free medication throughout the study, close monitoring and coordination of care with your physician per your consent. If you allow consent and qualify for a study, you may receive reimbursement for travel and inconvenience for each visit. |
| Study is available at: |
|
CTT Research, Inc
8340 Mission Rd
Suite 205
Prairie Village, KS 66206
View Clinic Location
If you meet the above criteria and live within 100 miles of this clinic please enter your information below and click "I Am Interested In This Study" to be contacted by the study coordinator.
or
Click "View Contact Phone Number" to get the clinic’s phone number. |